Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology

Neurobiology of Aging

Volumn 23, Issue 3, 2002, Pages 327-334

  Xiang, Zhongmin ^a   Ho, Lap ^a   Valdellon, Jennifer ^a   Borchelt, David ^b   Kelley, Kevin ^a   Spielman, Lauren ^a   Aisen, Paul S ^a   Pasinetti, Giulio Maria ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cell cycle; Cyclooxygenase; Inflammation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE 3; CHEMICAL COMPOUND; CYCLOOXYGENASE 2; FLAVOPERIDOL; PROTEIN; PROTEIN PRESENILIN; UNCLASSIFIED DRUG;

AGE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL CYCLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ENZYME ANALYSIS; HIPPOCAMPUS; IN VITRO STUDY; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RETINOBLASTOMA; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CASPASE 3; CASPASES; CELL CYCLE; CELL DEATH; CELLS, CULTURED; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PEPTIDE FRAGMENTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRANSGENES;

EID: 0036227488     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00282-2     Document Type: Article

References (44)

1. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease
2. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus
3. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
4. Epidemiologic clues to the causes and routes to prevention of Alzheimer disease
5. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs
6. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
7. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation
8. Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury
9. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures
10. Molecular pathology of cyclooxygenase-2 in neoplasia
11. Wortmannin enhances activation of CPP32 (Caspase-3) induced by TNF or anti-Fas
12. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3
13. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F × DP, in B-amyloid-induced neuronal death
14. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture
15. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis
16. Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death
17. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
18. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease
19. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
20. Effects of an Rb mutation in the mouse
21. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2
22. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
23. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
24. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease
25. Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease
26. The cell division cycle and the pathophysiology of Alzheimer's disease
27. Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex
28. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
29. Cell cycle regulators in neuronal death evoked by excitotoxic stress: Implications for neurodegeneration and its treatment
30. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
31. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
32. Abortive apoptosis in Alzheimer's disease
33. Cyclin' toward dementia: Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease
34. Interleukin-1 (IL-1) beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression
35. Tumor surveillance via the ARF-p53 pathway
36. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease
37. Risk of Alzheimer's disease and duration of NSAID use
38. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain
39. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
40. The retinoblastoma protein and cell cycle control
41. Unbiased stereological estimation of the number of neurons in the human hippocampus
42. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression
43. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
44. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases